Filing Details

Accession Number:
0000899140-24-000705
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2024-07-10 11:11:45
Reporting Period:
2024-06-23
Accepted Time:
2024-07-10 11:11:45
Original Submission Date:
2024-06-25
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1638287 Neurobo Pharmaceuticals Inc. NRBO Pharmaceutical Preparations (2834) 472389984
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1799260 Dong-A St Co., Ltd 64, Cheonho-Daero
Dongdaemun-Gu
Seoul M5 02587
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-06-23 2,544,530 $3.93 5,348,229 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. This amendment to Form 4 is being filed by the reporting person to correct a scrivener's error in the Form 4 filed by the reporting person on June 25, 2024 (the "Original Form 4"). The Original Form 4 incorrectly reported a $3.13 price per share of Common Stock acquired by the reporting person in the subject transaction. As reported in this amendment to Form 4, the price per share of Common Stock acquired by the reporting person in the subject transaction was $3.93 per share.